However, as the disease advances toward MASH, TBK1 kinase activity becomes markedly diminished despite relatively preserved total protein levels in mice, with reduced TBK1 expression in liver tissue of human MASH patients. This evidence concerns the gene TBK1 and metabolic dysfunction-associated steatohepatitis.